Related Experiment Video

Updated: May 31, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Mental Health Disorders in Pediatric Inflammatory Bowel Disease: Epidemiology, Mechanisms, and Interventions

Yu Liu1, Yibing Hu2, Jiajing Zheng1

  • 1Department of Pediatrics, Beilun District People's Hospital, Ningbo, Zhejiang, 315800, People's Republic of China.

Journal of Inflammation Research
|May 29, 2026
PubMed

Insights

Pediatric inflammatory bowel disease (IBD) is linked to a high prevalence of mental health disorders like depression and anxiety in children and adolescents. Early screening and integrated care are crucial for better outcomes.

Area of Science:

  • Gastroenterology and Psychiatry
  • Pediatric Health
  • Inflammatory Bowel Disease Research

Background:

  • Pediatric inflammatory bowel disease (IBD) presents significant psychological challenges beyond gastrointestinal symptoms.
  • Children and adolescents with IBD experience a higher prevalence of mental health disorders, including depression, anxiety, and sleep disturbances, compared to the general population.
  • Prevalence rates for mental disorders in pediatric IBD range from 42% to 73% based on psychiatric evaluations.

Purpose of the Study:

  • To synthesize current evidence on the association between pediatric IBD and mental health disorders.
  • To explore epidemiological data, pathophysiological mechanisms, and advancements in screening and intervention strategies for mental health in pediatric IBD.
  • To provide a focused review on pediatric-onset IBD, differentiating from reviews that combine adult and pediatric populations.

Main Methods:

  • Literature review synthesizing current evidence on pediatric IBD and mental health.
  • Focus on epidemiological data, underlying pathophysiological mechanisms, and screening/intervention strategies.
  • Analysis of studies examining the bidirectional relationship between intestinal inflammation and mental health.

Main Results:

  • A complex, bidirectional relationship exists between intestinal inflammation and mental health, mediated by gut-brain axis, immune, genetic, and medication-related factors.
  • Mental health disorders are frequently underrecognized and undertreated in pediatric IBD despite available screening tools.
  • Evidence for psychological and pharmacological interventions in pediatric populations is limited and often extrapolated from adult studies.

Conclusions:

  • Integrated multidisciplinary care, increased clinical awareness, and routine mental health screening are essential for improving outcomes in pediatric IBD.
  • Further large-scale, multi-center, longitudinal studies are required to elucidate mechanisms and optimize prevention and treatment strategies.
  • This review specifically addresses pediatric-onset IBD, offering a dedicated synthesis of mental health comorbidities in this age group.

Keywords:
anxietychildrendepressioninflammatory bowel diseasemental health disorders

More Related Videos

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...